| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 6.30e-06 | 14 | 53 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.01e-05 | 23 | 53 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 6.14e-05 | 29 | 53 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 6.14e-05 | 29 | 53 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | collagen V binding | 6.88e-05 | 5 | 53 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 9.97e-05 | 34 | 53 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.98e-04 | 49 | 53 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.55e-04 | 230 | 53 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 6.56e-04 | 149 | 53 | 4 | GO:1990782 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 8.52e-04 | 70 | 53 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 9.39e-04 | 164 | 53 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 9.63e-04 | 73 | 53 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.29e-03 | 815 | 53 | 8 | GO:0042803 | |
| GeneOntologyMolecularFunction | collagen binding | 1.30e-03 | 81 | 53 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.55e-03 | 188 | 53 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.62e-03 | 190 | 53 | 4 | GO:0004252 | |
| GeneOntologyMolecularFunction | heparin binding | 1.68e-03 | 192 | 53 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.76e-03 | 90 | 53 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 2.21e-03 | 207 | 53 | 4 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.41e-03 | 212 | 53 | 4 | GO:0017171 | |
| GeneOntologyMolecularFunction | histone kinase activity | 2.50e-03 | 28 | 53 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.57e-03 | 709 | 53 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 3.89e-03 | 764 | 53 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 4.02e-03 | 398 | 53 | 5 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 4.12e-03 | 1205 | 53 | 9 | GO:0046983 | |
| GeneOntologyMolecularFunction | fibronectin binding | 4.57e-03 | 38 | 53 | 2 | GO:0001968 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.37e-07 | 334 | 52 | 9 | GO:0051896 | |
| GeneOntologyBiologicalProcess | angiogenesis | HOXA5 CFH HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 PSG8 NOTCH1 | 1.43e-07 | 708 | 52 | 12 | GO:0001525 |
| GeneOntologyBiologicalProcess | blood coagulation | 2.67e-07 | 260 | 52 | 8 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 3.17e-07 | 266 | 52 | 8 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 3.36e-07 | 268 | 52 | 8 | GO:0007599 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 3.64e-07 | 375 | 52 | 9 | GO:0007162 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.25e-07 | 382 | 52 | 9 | GO:0043491 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | HGF THBS1 BTN2A2 ADRA2C CALCR CCN1 PSG3 PSG6 ROR2 PSG8 ALOX12B NOTCH1 | 6.43e-07 | 815 | 52 | 12 | GO:0043408 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | HOXA5 CFH HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 PSG8 NOTCH1 | 6.59e-07 | 817 | 52 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 8.32e-07 | 69 | 52 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 8.94e-07 | 70 | 52 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 9.36e-07 | 420 | 52 | 9 | GO:0045765 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.03e-06 | 72 | 52 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.14e-06 | 430 | 52 | 9 | GO:1901342 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 1.36e-06 | 571 | 52 | 10 | GO:0043410 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.43e-06 | 442 | 52 | 9 | GO:0050878 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.84e-06 | 147 | 52 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HOXA5 CFH MST1 HGF HSPG2 THBS1 CCN1 PSG3 PSG6 EGLN1 ROR2 LAMC3 PSG8 NOTCH1 | 2.01e-06 | 1269 | 52 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HOXA5 CFH PIKFYVE HGF HSPG2 THBS1 NRAP CCN1 PSG3 PSG6 LPA EGLN1 ROR2 PSG8 NOTCH1 | 2.34e-06 | 1483 | 52 | 15 | GO:0048646 |
| GeneOntologyBiologicalProcess | blood vessel development | HOXA5 CFH HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 PSG8 NOTCH1 | 2.53e-06 | 929 | 52 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | MAPK cascade | HGF THBS1 BTN2A2 ADRA2C CALCR CCN1 PSG3 PSG6 ROR2 PSG8 ALOX12B NOTCH1 | 2.56e-06 | 930 | 52 | 12 | GO:0000165 |
| GeneOntologyBiologicalProcess | tube morphogenesis | HOXA5 CFH MST1 HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 PSG8 NOTCH1 | 3.06e-06 | 1125 | 52 | 13 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.30e-06 | 91 | 52 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | wound healing | 3.49e-06 | 493 | 52 | 9 | GO:0042060 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | HOXA5 HGF ISLR2 BTN2A2 ADRA2C CCN1 PSG3 PSG6 GIMAP5 ROR2 PSG8 ACVR1B NOTCH1 | 3.57e-06 | 1141 | 52 | 13 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 3.68e-06 | 93 | 52 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | vasculature development | HOXA5 CFH HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 PSG8 NOTCH1 | 3.91e-06 | 969 | 52 | 12 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of coagulation | 4.30e-06 | 96 | 52 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.76e-06 | 98 | 52 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 5.03e-06 | 385 | 52 | 8 | GO:0070372 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.39e-06 | 14 | 52 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 5.56e-06 | 178 | 52 | 6 | GO:0022612 | |
| GeneOntologyBiologicalProcess | tube development | HOXA5 CFH MST1 HGF HSPG2 THBS1 CCN1 PSG3 PSG6 LPA EGLN1 CAT PSG8 NOTCH1 | 6.44e-06 | 1402 | 52 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.73e-06 | 15 | 52 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.73e-06 | 15 | 52 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.73e-06 | 15 | 52 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.73e-06 | 15 | 52 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.27e-06 | 16 | 52 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | circulatory system development | HOXA5 CFH HGF HSPG2 THBS1 NRAP CCN1 PSG3 PSG6 LPA EGLN1 PSG8 ACVR1B NOTCH1 | 8.89e-06 | 1442 | 52 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 9.17e-06 | 418 | 52 | 8 | GO:0070371 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.00e-05 | 17 | 52 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.00e-05 | 17 | 52 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.00e-05 | 17 | 52 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | liver development | 1.15e-05 | 202 | 52 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.20e-05 | 18 | 52 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.25e-05 | 205 | 52 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | HOXA5 HGF HSPG2 THBS1 BTN2A2 ADRA2C CALCR PSG3 PSG6 GIMAP5 LPA PSG8 EPX NOTCH1 | 1.27e-05 | 1488 | 52 | 14 | GO:0051241 |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production | 1.42e-05 | 444 | 52 | 8 | GO:0001818 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.50e-05 | 124 | 52 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.62e-05 | 126 | 52 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.67e-05 | 20 | 52 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | 1.76e-05 | 603 | 52 | 9 | GO:0050673 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.95e-05 | 21 | 52 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.95e-05 | 21 | 52 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.95e-05 | 21 | 52 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.96e-05 | 334 | 52 | 7 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.96e-05 | 334 | 52 | 7 | GO:0001894 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.25e-05 | 22 | 52 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | connective tissue development | 2.33e-05 | 343 | 52 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.45e-05 | 67 | 52 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.58e-05 | 23 | 52 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.58e-05 | 23 | 52 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.91e-05 | 70 | 52 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.95e-05 | 24 | 52 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.95e-05 | 24 | 52 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.95e-05 | 24 | 52 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.08e-05 | 71 | 52 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 3.18e-05 | 497 | 52 | 8 | GO:0002697 | |
| GeneOntologyBiologicalProcess | cartilage development | 3.25e-05 | 243 | 52 | 6 | GO:0051216 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.34e-05 | 25 | 52 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.34e-05 | 25 | 52 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | response to wounding | 3.54e-05 | 659 | 52 | 9 | GO:0009611 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | MST1 HGF THBS1 CCN1 PSG3 PSG6 LPA ROR2 PSG8 ACVR1B ATP1B2 NOTCH1 | 3.67e-05 | 1211 | 52 | 12 | GO:0030334 |
| GeneOntologyBiologicalProcess | female pregnancy | 3.73e-05 | 249 | 52 | 6 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 3.99e-05 | 252 | 52 | 6 | GO:0022408 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 4.03e-05 | 76 | 52 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 4.04e-05 | 514 | 52 | 8 | GO:0050678 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.24e-05 | 27 | 52 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | HOXA5 MST1 HGF THBS1 CALCR CCN1 GIMAP5 ACVR1B EPX NOS2 ALOX12B NOTCH1 TP53BP1 | 4.50e-05 | 1446 | 52 | 13 | GO:0010628 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | HOXA5 CFH CALCR PSG3 PSG6 GIMAP5 PSG8 ACVR1B CUBN ATP1B2 NOTCH1 | 4.69e-05 | 1043 | 52 | 11 | GO:0048871 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 4.74e-05 | 28 | 52 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | platelet activation | 4.81e-05 | 158 | 52 | 5 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 4.83e-05 | 686 | 52 | 9 | GO:0043549 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 4.93e-05 | 80 | 52 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.93e-05 | 80 | 52 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 4.95e-05 | 262 | 52 | 6 | GO:0048771 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 5.27e-05 | 29 | 52 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | epithelium development | HOXA5 CFH MST1 HGF CCN1 PSG3 PSG6 ROR2 CAT PSG8 ACVR1B ALOX12B NOTCH1 | 5.30e-05 | 1469 | 52 | 13 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 5.72e-05 | 540 | 52 | 8 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 5.73e-05 | 269 | 52 | 6 | GO:0010594 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 6.09e-05 | 166 | 52 | 5 | GO:0061041 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 6.25e-05 | 85 | 52 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | MST1 HGF THBS1 CCN1 PSG3 PSG6 LPA ROR2 PSG8 ACVR1B ATP1B2 NOTCH1 | 6.29e-05 | 1280 | 52 | 12 | GO:2000145 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 6.46e-05 | 31 | 52 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 6.67e-05 | 405 | 52 | 7 | GO:0033674 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 6.85e-05 | 87 | 52 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 6.98e-05 | 1090 | 52 | 11 | GO:0022603 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 7.00e-05 | 171 | 52 | 5 | GO:0050868 | |
| GeneOntologyBiologicalProcess | cytokine production | 7.04e-05 | 1091 | 52 | 11 | GO:0001816 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 7.12e-05 | 32 | 52 | 3 | GO:0045779 | |
| GeneOntologyCellularComponent | cell surface | CFH ISLR2 THBS1 BTN2A2 RTP1 PSG3 PSG6 LPA ROR2 PSG8 ACVR1B CUBN ATP1B2 NOTCH1 | 4.53e-07 | 1111 | 53 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | 5.61e-06 | 519 | 53 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 8.42e-06 | 16 | 53 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.26e-05 | 530 | 53 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.01e-05 | 90 | 53 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | receptor complex | 9.99e-05 | 581 | 53 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.30e-04 | 656 | 53 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.34e-04 | 658 | 53 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | side of membrane | 3.20e-04 | 875 | 53 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 6.42e-04 | 155 | 53 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 6.57e-04 | 67 | 53 | 3 | GO:0031093 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 6.73e-04 | 157 | 53 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 9.06e-04 | 170 | 53 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | secretory granule | 9.27e-04 | 1014 | 53 | 9 | GO:0030141 | |
| GeneOntologyCellularComponent | secretory vesicle | 1.02e-03 | 1246 | 53 | 10 | GO:0099503 | |
| GeneOntologyCellularComponent | secretory granule lumen | 1.37e-03 | 325 | 53 | 5 | GO:0034774 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.41e-03 | 487 | 53 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.47e-03 | 330 | 53 | 5 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.51e-03 | 332 | 53 | 5 | GO:0031983 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.70e-03 | 93 | 53 | 3 | GO:0031091 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.90e-03 | 350 | 53 | 5 | GO:0098802 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.97e-03 | 98 | 53 | 3 | GO:0060170 | |
| GeneOntologyCellularComponent | adherens junction | 2.04e-03 | 212 | 53 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | anchoring junction | 3.01e-03 | 976 | 53 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.51e-03 | 785 | 53 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.70e-03 | 591 | 53 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 3.73e-03 | 592 | 53 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.64e-03 | 431 | 53 | 5 | GO:0031253 | |
| MousePheno | abnormal response to injury | 3.15e-06 | 607 | 46 | 11 | MP:0005164 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.20e-05 | 17 | 46 | 3 | MP:0031047 | |
| MousePheno | abnormal wound healing | 3.79e-05 | 193 | 46 | 6 | MP:0005023 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.25e-05 | 21 | 46 | 3 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 6.43e-05 | 24 | 46 | 3 | MP:0014172 | |
| MousePheno | abnormal involution of the mammary gland | 6.43e-05 | 24 | 46 | 3 | MP:0006271 | |
| MousePheno | increased abdominal fat pad weight | 9.23e-05 | 27 | 46 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.03e-04 | 28 | 46 | 3 | MP:0020950 | |
| MousePheno | abnormal respiratory bronchiole morphology | 1.05e-04 | 5 | 46 | 2 | MP:0004389 | |
| MousePheno | abnormal eyelid morphology | 1.08e-04 | 233 | 46 | 6 | MP:0001340 | |
| MousePheno | abnormal colon morphology | 1.36e-04 | 152 | 46 | 5 | MP:0000495 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.41e-04 | 31 | 46 | 3 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.41e-04 | 31 | 46 | 3 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.03e-04 | 35 | 46 | 3 | MP:0031618 | |
| MousePheno | abnormal conjunctival epithelium morphology | 2.20e-04 | 7 | 46 | 2 | MP:0004481 | |
| MousePheno | abnormal muscle triglyceride level | 2.21e-04 | 36 | 46 | 3 | MP:0031412 | |
| MousePheno | internal hemorrhage | 2.49e-04 | 387 | 46 | 7 | MP:0001634 | |
| MousePheno | hemorrhage | 2.64e-04 | 664 | 46 | 9 | MP:0001914 | |
| MousePheno | decreased muscle cell glucose uptake | 2.80e-04 | 39 | 46 | 3 | MP:0030022 | |
| MousePheno | abnormal blood circulation | 3.44e-04 | 845 | 46 | 10 | MP:0002128 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.02e-04 | 44 | 46 | 3 | MP:0031023 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 4.69e-04 | 10 | 46 | 2 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 4.69e-04 | 10 | 46 | 2 | MP:0011507 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 4.89e-04 | 47 | 46 | 3 | MP:0031617 | |
| MousePheno | dilated liver sinusoidal space | 5.20e-04 | 48 | 46 | 3 | MP:0000602 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 5.53e-04 | 49 | 46 | 3 | MP:0020948 | |
| MousePheno | neoplasm | 6.27e-04 | 747 | 46 | 9 | MP:0002006 | |
| MousePheno | abnormal optic choroid morphology | 6.58e-04 | 52 | 46 | 3 | MP:0005098 | |
| MousePheno | abnormal bronchus epithelium morphology | 6.85e-04 | 12 | 46 | 2 | MP:0010943 | |
| MousePheno | hemoperitoneum | 6.85e-04 | 12 | 46 | 2 | MP:0005435 | |
| MousePheno | decreased cellular glucose uptake | 6.96e-04 | 53 | 46 | 3 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 7.35e-04 | 54 | 46 | 3 | MP:0010953 | |
| MousePheno | abnormal conjunctiva morphology | 8.07e-04 | 13 | 46 | 2 | MP:0001310 | |
| Domain | Kringle | 1.34e-07 | 17 | 53 | 4 | IPR000001 | |
| Domain | Kringle_CS | 1.34e-07 | 17 | 53 | 4 | IPR018056 | |
| Domain | KRINGLE_2 | 1.34e-07 | 17 | 53 | 4 | PS50070 | |
| Domain | Kringle | 1.34e-07 | 17 | 53 | 4 | PF00051 | |
| Domain | KRINGLE_1 | 1.34e-07 | 17 | 53 | 4 | PS00021 | |
| Domain | KR | 1.34e-07 | 17 | 53 | 4 | SM00130 | |
| Domain | Kringle-like | 1.96e-06 | 32 | 53 | 4 | IPR013806 | |
| Domain | HGF-like | 7.90e-06 | 2 | 53 | 2 | IPR024174 | |
| Domain | DEP | 3.20e-05 | 22 | 53 | 3 | PF00610 | |
| Domain | DEP | 3.20e-05 | 22 | 53 | 3 | PS50186 | |
| Domain | DEP | 3.20e-05 | 22 | 53 | 3 | SM00049 | |
| Domain | DEP_dom | 3.67e-05 | 23 | 53 | 3 | IPR000591 | |
| Domain | Ig_2 | 5.44e-05 | 73 | 53 | 4 | PF13895 | |
| Domain | PAN_AP | 7.86e-05 | 5 | 53 | 2 | SM00473 | |
| Domain | Growth_fac_rcpt_ | 7.92e-05 | 156 | 53 | 5 | IPR009030 | |
| Domain | PAN | 1.64e-04 | 7 | 53 | 2 | PS50948 | |
| Domain | Pan_app | 1.64e-04 | 7 | 53 | 2 | IPR003609 | |
| Domain | PAN_1 | 1.64e-04 | 7 | 53 | 2 | PF00024 | |
| Domain | V-set | 1.72e-04 | 184 | 53 | 5 | PF07686 | |
| Domain | IG | 1.77e-04 | 421 | 53 | 7 | SM00409 | |
| Domain | Ig_sub | 1.77e-04 | 421 | 53 | 7 | IPR003599 | |
| Domain | LAMININ_IVA | 2.19e-04 | 8 | 53 | 2 | PS51115 | |
| Domain | Laminin_B | 2.19e-04 | 8 | 53 | 2 | PF00052 | |
| Domain | LamB | 2.19e-04 | 8 | 53 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.19e-04 | 8 | 53 | 2 | IPR000034 | |
| Domain | Ig_V-set | 2.47e-04 | 199 | 53 | 5 | IPR013106 | |
| Domain | Peptidase_S1A | 2.96e-04 | 113 | 53 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 3.16e-04 | 115 | 53 | 4 | PS50240 | |
| Domain | Tryp_SPc | 3.38e-04 | 117 | 53 | 4 | SM00020 | |
| Domain | Trypsin | 3.84e-04 | 121 | 53 | 4 | PF00089 | |
| Domain | Trypsin_dom | 3.84e-04 | 121 | 53 | 4 | IPR001254 | |
| Domain | EGF_CA | 3.96e-04 | 122 | 53 | 4 | SM00179 | |
| Domain | Peptidase_S1_PA | 4.09e-04 | 123 | 53 | 4 | IPR009003 | |
| Domain | EGF-like_Ca-bd_dom | 4.21e-04 | 124 | 53 | 4 | IPR001881 | |
| Domain | IG_LIKE | 4.50e-04 | 491 | 53 | 7 | PS50835 | |
| Domain | Ig-like_dom | 5.20e-04 | 503 | 53 | 7 | IPR007110 | |
| Domain | - | 5.22e-04 | 663 | 53 | 8 | 2.60.40.10 | |
| Domain | IGc2 | 5.30e-04 | 235 | 53 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.30e-04 | 235 | 53 | 5 | IPR003598 | |
| Domain | EGF | 5.30e-04 | 235 | 53 | 5 | SM00181 | |
| Domain | EGF-like_dom | 6.89e-04 | 249 | 53 | 5 | IPR000742 | |
| Domain | EGF_1 | 7.67e-04 | 255 | 53 | 5 | PS00022 | |
| Domain | Ig-like_fold | 7.88e-04 | 706 | 53 | 8 | IPR013783 | |
| Domain | EGF-like_CS | 8.51e-04 | 261 | 53 | 5 | IPR013032 | |
| Domain | EGF_2 | 9.11e-04 | 265 | 53 | 5 | PS01186 | |
| Domain | EGF_CA | 1.87e-03 | 86 | 53 | 3 | PF07645 | |
| Domain | ig | 2.06e-03 | 190 | 53 | 4 | PF00047 | |
| Domain | Immunoglobulin | 2.06e-03 | 190 | 53 | 4 | IPR013151 | |
| Domain | VWC | 2.85e-03 | 28 | 53 | 2 | PF00093 | |
| Domain | EGF_LAM_2 | 3.27e-03 | 30 | 53 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 3.27e-03 | 30 | 53 | 2 | PS01248 | |
| Domain | EGF_3 | 4.42e-03 | 235 | 53 | 4 | PS50026 | |
| Domain | Laminin_EGF | 4.43e-03 | 35 | 53 | 2 | PF00053 | |
| Domain | EGF_Lam | 4.43e-03 | 35 | 53 | 2 | SM00180 | |
| Domain | VWFC_1 | 4.68e-03 | 36 | 53 | 2 | PS01208 | |
| Domain | VWC | 5.20e-03 | 38 | 53 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.20e-03 | 38 | 53 | 2 | PS50184 | |
| Domain | Laminin_EGF | 5.20e-03 | 38 | 53 | 2 | IPR002049 | |
| Domain | EGF | 5.49e-03 | 126 | 53 | 3 | PF00008 | |
| Domain | VWF_dom | 6.33e-03 | 42 | 53 | 2 | IPR001007 | |
| Pathway | REACTOME_HEMOSTASIS | 7.72e-07 | 571 | 43 | 11 | MM14472 | |
| Pathway | REACTOME_HEMOSTASIS | 2.84e-05 | 679 | 43 | 10 | M8395 | |
| Pubmed | 3.80e-07 | 39 | 53 | 4 | 1676977 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 9.45e-07 | 13 | 53 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 9.45e-07 | 13 | 53 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 9.45e-07 | 13 | 53 | 3 | 16638824 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 20044046 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 32150576 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 6265583 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 9.45e-07 | 13 | 53 | 3 | 12832451 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 9.45e-07 | 13 | 53 | 3 | 21670291 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 22162753 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 2702644 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 8380065 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 1279194 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 25724769 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 9.45e-07 | 13 | 53 | 3 | 22092845 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 11801635 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 9.45e-07 | 13 | 53 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 9.45e-07 | 13 | 53 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 9.45e-07 | 13 | 53 | 3 | 23800882 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 19285068 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 21760897 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 9.45e-07 | 13 | 53 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 9.45e-07 | 13 | 53 | 3 | 39168268 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 8402684 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 16619040 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 9.45e-07 | 13 | 53 | 3 | 8209741 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 9.45e-07 | 13 | 53 | 3 | 21949477 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 26219866 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 2133556 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 32521208 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 19406938 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 9.45e-07 | 13 | 53 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 9.45e-07 | 13 | 53 | 3 | 19358828 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 16680193 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 9.45e-07 | 13 | 53 | 3 | 34058224 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 10964771 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 32169849 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 9.45e-07 | 13 | 53 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 9.45e-07 | 13 | 53 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 9.45e-07 | 13 | 53 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 9.45e-07 | 13 | 53 | 3 | 23935487 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 15331748 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 9.45e-07 | 13 | 53 | 3 | 22406619 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 9.45e-07 | 13 | 53 | 3 | 25972571 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 19008452 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 9.45e-07 | 13 | 53 | 3 | 15220458 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 18843289 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 15207636 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 21081647 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 11133662 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 11483763 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 2164599 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 29396368 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 18003729 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 9.45e-07 | 13 | 53 | 3 | 33352461 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 38381498 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 20739537 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 9.45e-07 | 13 | 53 | 3 | 27695943 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 20404914 | ||
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 9.45e-07 | 13 | 53 | 3 | 32027621 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 9.45e-07 | 13 | 53 | 3 | 27777319 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 18848945 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.20e-06 | 14 | 53 | 3 | 34666041 | |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.20e-06 | 14 | 53 | 3 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.20e-06 | 14 | 53 | 3 | 32209360 | |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 11994468 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 11850617 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.20e-06 | 14 | 53 | 3 | 26196244 | |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 8896983 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 22962327 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 17623671 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.20e-06 | 14 | 53 | 3 | 18794798 | |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 23469261 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 18454175 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 22159884 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 29907459 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 36719377 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 23780386 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 28567513 | ||
| Interaction | CRP interactions | 1.77e-06 | 77 | 53 | 5 | int:CRP | |
| Cytoband | 19q13.2 | 4.01e-05 | 164 | 53 | 4 | 19q13.2 | |
| Cytoband | 11p13 | 1.93e-03 | 56 | 53 | 2 | 11p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 2.60e-03 | 65 | 53 | 2 | chr11p13 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.08e-06 | 11 | 35 | 3 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.68e-04 | 163 | 35 | 4 | 590 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.26e-07 | 194 | 53 | 7 | M39122 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.81e-06 | 182 | 53 | 6 | MM993 | |
| Coexpression | DASU_IL6_SIGNALING_SCAR_DN | 4.29e-06 | 16 | 53 | 3 | M1711 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 7.92e-06 | 135 | 53 | 5 | M5825 | |
| Coexpression | NABA_MATRISOME | 2.93e-05 | 1008 | 53 | 10 | MM17056 | |
| Coexpression | JONES_OVARY_NK_CELL | 3.20e-05 | 89 | 53 | 4 | M48353 | |
| Coexpression | NABA_MATRISOME | 3.41e-05 | 1026 | 53 | 10 | M5889 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 3.71e-05 | 32 | 53 | 3 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 4.88e-05 | 35 | 53 | 3 | MM757 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.10e-04 | 546 | 53 | 7 | M3837 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.27e-04 | 48 | 53 | 3 | MM531 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.41e-04 | 568 | 53 | 7 | MM3824 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.62e-04 | 135 | 53 | 4 | MM965 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 1.67e-04 | 256 | 53 | 5 | M10952 | |
| Coexpression | HALLMARK_COAGULATION | 1.76e-04 | 138 | 53 | 4 | M5946 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP | 1.86e-04 | 140 | 53 | 4 | M9377 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 2.02e-04 | 143 | 53 | 4 | MM989 | |
| Coexpression | NABA_CORE_MATRISOME | 2.14e-04 | 270 | 53 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.33e-04 | 275 | 53 | 5 | M5884 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 2.34e-04 | 59 | 53 | 3 | M47993 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 2.43e-04 | 436 | 53 | 6 | MM1326 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.32e-06 | 97 | 53 | 5 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 6.03e-05 | 85 | 53 | 4 | GSM777067_100 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_NA_vs_Mesoderm Day 15-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 8.32e-05 | 179 | 53 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_NA_vs_Mesoderm Day 15-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 8.32e-05 | 179 | 53 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.27e-04 | 453 | 53 | 7 | GSM777067_500 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-09 | 164 | 53 | 7 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-09 | 197 | 53 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-09 | 197 | 53 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.73e-09 | 198 | 53 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.87e-09 | 199 | 53 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-08 | 171 | 53 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-08 | 171 | 53 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-08 | 178 | 53 | 6 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-08 | 178 | 53 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-08 | 180 | 53 | 6 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-08 | 180 | 53 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-08 | 180 | 53 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-08 | 185 | 53 | 6 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-08 | 185 | 53 | 6 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.99e-08 | 186 | 53 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 192 | 53 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 192 | 53 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 192 | 53 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 193 | 53 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 193 | 53 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-07 | 194 | 53 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-07 | 195 | 53 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 195 | 53 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 195 | 53 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-07 | 195 | 53 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 195 | 53 | 6 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 53 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 53 | 6 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 53 | 6 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 53 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 53 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 197 | 53 | 6 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 197 | 53 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 197 | 53 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 197 | 53 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-07 | 198 | 53 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-07 | 198 | 53 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-06 | 159 | 53 | 5 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 169 | 53 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 182 | 53 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 182 | 53 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-06 | 184 | 53 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-06 | 184 | 53 | 5 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-06 | 187 | 53 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.87e-06 | 187 | 53 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 189 | 53 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 189 | 53 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 189 | 53 | 5 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 190 | 53 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 190 | 53 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.10e-06 | 190 | 53 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 190 | 53 | 5 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-06 | 191 | 53 | 5 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-06 | 191 | 53 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-06 | 191 | 53 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-06 | 191 | 53 | 5 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 192 | 53 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 192 | 53 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 192 | 53 | 5 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-06 | 193 | 53 | 5 | 7c0d84b92470bfda2db1e5007feee7c1235a0a78 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-06 | 193 | 53 | 5 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.43e-06 | 194 | 53 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.43e-06 | 194 | 53 | 5 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-06 | 194 | 53 | 5 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.43e-06 | 194 | 53 | 5 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 195 | 53 | 5 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 195 | 53 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 195 | 53 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-06 | 195 | 53 | 5 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | Mesenchymal_cells|World / Lineage and Cell class | 3.52e-06 | 195 | 53 | 5 | 380eb436baa371f7aa2dc0c4a594afb173b5a25b | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.52e-06 | 195 | 53 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.52e-06 | 195 | 53 | 5 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-06 | 195 | 53 | 5 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-06 | 196 | 53 | 5 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-06 | 196 | 53 | 5 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 197 | 53 | 5 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 197 | 53 | 5 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 197 | 53 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.70e-06 | 197 | 53 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 197 | 53 | 5 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 197 | 53 | 5 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-06 | 198 | 53 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.79e-06 | 198 | 53 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.79e-06 | 198 | 53 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.89e-06 | 199 | 53 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.89e-06 | 199 | 53 | 5 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.89e-06 | 199 | 53 | 5 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.89e-06 | 199 | 53 | 5 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| Computational | Ovary genes. | 1.84e-04 | 368 | 36 | 7 | MODULE_1 | |
| Computational | Neighborhood of PAX7 | 2.26e-04 | 266 | 36 | 6 | MORF_PAX7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.07e-04 | 50 | 36 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5 | |
| Computational | Neighborhood of ATF2 | 7.15e-04 | 330 | 36 | 6 | MORF_ATF2 | |
| Drug | 13-HPODE | 8.03e-07 | 74 | 53 | 5 | CID000001426 | |
| Drug | aminostimil | 5.31e-06 | 15 | 53 | 3 | CID000021450 | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; PC3; HT_HG-U133A | 6.36e-06 | 197 | 53 | 6 | 4674_UP | |
| Drug | sulindac sulfide | 1.43e-05 | 227 | 53 | 6 | ctd:C025462 | |
| Drug | tranexamic acid | 1.50e-05 | 64 | 53 | 4 | CID000005526 | |
| Drug | Glyco-SNAP-2 | 1.59e-05 | 3 | 53 | 2 | CID003413551 | |
| Drug | Niacin | 1.79e-05 | 139 | 53 | 5 | ctd:D009525 | |
| Drug | Rgd Peptide | 1.91e-05 | 239 | 53 | 6 | CID000104802 | |
| Drug | quinocetone | 2.35e-05 | 248 | 53 | 6 | ctd:C502851 | |
| Drug | AC1O0B8G | 3.20e-05 | 262 | 53 | 6 | CID000091605 | |
| Drug | NS-398 | 3.34e-05 | 264 | 53 | 6 | CID000004553 | |
| Drug | Astemizole | 4.00e-05 | 82 | 53 | 4 | ctd:D016589 | |
| Drug | genistein | PIKFYVE MST1 HGF HSPG2 THBS1 GIMAP5 CAT LAMC3 EPX NOS2 ALOX12B | 4.30e-05 | 1117 | 53 | 11 | CID005280961 |
| Drug | lucigenin | 4.40e-05 | 84 | 53 | 4 | CID000065099 | |
| Drug | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 5.29e-05 | 5 | 53 | 2 | ctd:C478738 | |
| Drug | vitamin B | 6.19e-05 | 295 | 53 | 6 | CID000000936 | |
| Drug | iodoacetamide | 6.33e-05 | 181 | 53 | 5 | CID000003727 | |
| Drug | SB203580 | 6.51e-05 | 771 | 53 | 9 | CID000176155 | |
| Drug | creatinine | 7.05e-05 | 302 | 53 | 6 | CID000000588 | |
| Drug | Caffeic Acid-13C3 | 7.12e-05 | 95 | 53 | 4 | CID000002518 | |
| Drug | Factor Xiiib | 7.40e-05 | 35 | 53 | 3 | CID000126166 | |
| Drug | phorbol-12-acetate | 7.93e-05 | 6 | 53 | 2 | CID000499952 | |
| Drug | costunolide | 7.93e-05 | 6 | 53 | 2 | ctd:C002602 | |
| Drug | indamine | 7.93e-05 | 6 | 53 | 2 | CID000010841 | |
| Drug | diffractaic acid | 7.93e-05 | 6 | 53 | 2 | CID000094870 | |
| Drug | Qb-1 | 7.93e-05 | 6 | 53 | 2 | CID000194703 | |
| Drug | AEBSF | 8.16e-05 | 191 | 53 | 5 | CID000001701 | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 2893_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 4960_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 4309_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 4593_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 3907_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 6830_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 3681_UP | |
| Drug | Trolox | 1.01e-04 | 104 | 53 | 4 | CID000040634 | |
| Drug | Safironil | 1.11e-04 | 7 | 53 | 2 | CID000065973 | |
| Drug | pramiracetam | 1.11e-04 | 7 | 53 | 2 | CID000051711 | |
| Drug | hydroxyl radical | 1.16e-04 | 206 | 53 | 5 | CID000157350 | |
| Drug | malondialdehyde | 1.36e-04 | 213 | 53 | 5 | CID000010964 | |
| Drug | AC1L1IPV | 1.38e-04 | 43 | 53 | 3 | CID000004683 | |
| Drug | LMWH | 1.38e-04 | 663 | 53 | 8 | CID000000772 | |
| Drug | Raloxifene Hydrochloride | 1.46e-04 | 857 | 53 | 9 | ctd:D020849 | |
| Drug | W-13 | 1.47e-04 | 44 | 53 | 3 | CID000004299 | |
| Drug | SNC-121 | 1.48e-04 | 8 | 53 | 2 | CID000197687 | |
| Drug | Glycosides | 1.48e-04 | 8 | 53 | 2 | ctd:D006027 | |
| Drug | AC1L1AL2 | 1.49e-04 | 115 | 53 | 4 | CID000001035 | |
| Drug | TXB2 (thromboxane B2 | 1.65e-04 | 118 | 53 | 4 | CID000005461 | |
| Drug | thiobarbituric acid | 1.65e-04 | 118 | 53 | 4 | CID002723628 | |
| Drug | AGEPC | 1.73e-04 | 356 | 53 | 6 | CID000461545 | |
| Drug | tricine | 1.80e-04 | 47 | 53 | 3 | CID000079784 | |
| Drug | indomethacin | 1.81e-04 | 690 | 53 | 8 | CID000003715 | |
| Drug | bifendate | 1.89e-04 | 9 | 53 | 2 | ctd:C465548 | |
| Drug | deuterohemin | 1.89e-04 | 9 | 53 | 2 | CID003082177 | |
| Drug | neohesperidin dihydrochalcone | 1.89e-04 | 9 | 53 | 2 | ctd:C013613 | |
| Drug | DIMBOA | 2.03e-04 | 49 | 53 | 3 | CID000002358 | |
| Drug | pyrogallol | 2.16e-04 | 50 | 53 | 3 | CID000001057 | |
| Drug | eicosatetraynoic acid | 2.29e-04 | 51 | 53 | 3 | CID000135235 | |
| Drug | rebamipide | 2.29e-04 | 51 | 53 | 3 | CID000005042 | |
| Drug | Adenosine Diphosphate | 2.29e-04 | 51 | 53 | 3 | ctd:D000244 | |
| Drug | Methylprednisolone | 2.32e-04 | 129 | 53 | 4 | ctd:D008775 | |
| Drug | acridine yellow | 2.36e-04 | 10 | 53 | 2 | CID000007081 | |
| Drug | carbon tetrachloride | 2.37e-04 | 240 | 53 | 5 | CID000005943 | |
| Disease | pancreatic cancer (is_marker_for) | 8.81e-07 | 101 | 51 | 5 | DOID:1793 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.66e-06 | 64 | 51 | 4 | DOID:4947 (is_marker_for) | |
| Disease | tyrosine-protein kinase transmembrane receptor ROR2 measurement | 8.78e-06 | 3 | 51 | 2 | EFO_0803209 | |
| Disease | tensin-2 measurement | 8.78e-06 | 3 | 51 | 2 | EFO_0802122 | |
| Disease | protein YIPF6 measurement | 8.78e-06 | 3 | 51 | 2 | EFO_0802969 | |
| Disease | Reperfusion Injury | 1.73e-05 | 89 | 51 | 4 | C0035126 | |
| Disease | E3 ubiquitin-protein ligase RNF149 measurement | 1.75e-05 | 4 | 51 | 2 | EFO_0802511 | |
| Disease | rap guanine nucleotide exchange factor 5 measurement | 1.75e-05 | 4 | 51 | 2 | EFO_0802989 | |
| Disease | zinc transporter 3 measurement | 2.92e-05 | 5 | 51 | 2 | EFO_0803287 | |
| Disease | Bonnevie-Ullrich Syndrome | 2.92e-05 | 5 | 51 | 2 | C1527168 | |
| Disease | toll-like receptor 1 measurement | 2.92e-05 | 5 | 51 | 2 | EFO_0803159 | |
| Disease | tachykinin-4 measurement | 2.92e-05 | 5 | 51 | 2 | EFO_0803137 | |
| Disease | serine/threonine-protein kinase Chk1 measurement | 2.92e-05 | 5 | 51 | 2 | EFO_0021965 | |
| Disease | Turner Syndrome | 2.92e-05 | 5 | 51 | 2 | C0041408 | |
| Disease | membrane-associated progesterone receptor component 2 measurement | 2.92e-05 | 5 | 51 | 2 | EFO_0801796 | |
| Disease | Gonadal Dysgenesis, 45,X | 2.92e-05 | 5 | 51 | 2 | C0242526 | |
| Disease | pre-mRNA-processing factor 6 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0802894 | |
| Disease | E3 ubiquitin-protein ligase RNF128 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0801555 | |
| Disease | thymidine kinase, cytosolic measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0020773 | |
| Disease | rab9 effector protein with kelch motifs measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0801984 | |
| Disease | o-acetyl-ADP-ribose deacetylase MACROD1 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0802827 | |
| Disease | galectin-7 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0022034 | |
| Disease | thioredoxin-interacting protein measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0803149 | |
| Disease | ribosome biogenesis protein TSR3 homolog measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0803025 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0021905 | |
| Disease | leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0802689 | |
| Disease | leucine-rich repeat-containing protein 74A measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0801763 | |
| Disease | interleukin-23 receptor measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0801725 | |
| Disease | secreted frizzled-related protein 2 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0802039 | |
| Disease | DNA-binding protein SATB2 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0802484 | |
| Disease | Cholangitis, Sclerosing | 4.37e-05 | 6 | 51 | 2 | C0008313 | |
| Disease | myotubularin-related protein 1 measurement | 6.12e-05 | 7 | 51 | 2 | EFO_0802773 | |
| Disease | kv channel-interacting protein 1 measurement | 6.12e-05 | 7 | 51 | 2 | EFO_0801751 | |
| Disease | r-spondin-3 measurement | 6.12e-05 | 7 | 51 | 2 | EFO_0021878 | |
| Disease | RNA polymerase II elongation factor ELL measurement | 6.12e-05 | 7 | 51 | 2 | EFO_0802028 | |
| Disease | angle-closure glaucoma (is_implicated_in) | 6.12e-05 | 7 | 51 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 8.15e-05 | 8 | 51 | 2 | EFO_0801513 | |
| Disease | Primary sclerosing cholangitis | 8.15e-05 | 8 | 51 | 2 | C0566602 | |
| Disease | growth factor receptor-bound protein 7 measurement | 8.15e-05 | 8 | 51 | 2 | EFO_0801659 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 8.15e-05 | 8 | 51 | 2 | EFO_0008309 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 1.05e-04 | 9 | 51 | 2 | EFO_0801514 | |
| Disease | Marfan Syndrome, Type I | 1.05e-04 | 9 | 51 | 2 | C4721845 | |
| Disease | familial Mediterranean fever (is_marker_for) | 1.05e-04 | 9 | 51 | 2 | DOID:2987 (is_marker_for) | |
| Disease | RNA-binding protein 24 measurement | 1.05e-04 | 9 | 51 | 2 | EFO_0802030 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 1.31e-04 | 10 | 51 | 2 | EFO_0020778 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 1.31e-04 | 10 | 51 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 1.31e-04 | 10 | 51 | 2 | EFO_0008252 | |
| Disease | Colonic Neoplasms | 1.40e-04 | 152 | 51 | 4 | C0009375 | |
| Disease | cytochrome p450 3a4 measurement | 1.59e-04 | 11 | 51 | 2 | EFO_0020303 | |
| Disease | Marfan Syndrome | 1.59e-04 | 11 | 51 | 2 | C0024796 | |
| Disease | guanylate-binding protein 6 measurement | 1.59e-04 | 11 | 51 | 2 | EFO_0801662 | |
| Disease | Malignant tumor of colon | 1.67e-04 | 159 | 51 | 4 | C0007102 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.71e-04 | 160 | 51 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | neovascular inflammatory vitreoretinopathy (is_marker_for) | 1.91e-04 | 12 | 51 | 2 | DOID:9719 (is_marker_for) | |
| Disease | coronary artery disease (is_marker_for) | 2.16e-04 | 67 | 51 | 3 | DOID:3393 (is_marker_for) | |
| Disease | Reactive Hyperemia | 2.26e-04 | 13 | 51 | 2 | C0178824 | |
| Disease | lung disease (implicated_via_orthology) | 2.26e-04 | 13 | 51 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | Venous Engorgement | 2.26e-04 | 13 | 51 | 2 | C0042484 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.26e-04 | 13 | 51 | 2 | EFO_0802114 | |
| Disease | Active Hyperemia | 2.26e-04 | 13 | 51 | 2 | C0333233 | |
| Disease | Hyperemia | 2.26e-04 | 13 | 51 | 2 | C0020452 | |
| Disease | rheumatoid arthritis (is_marker_for) | 2.35e-04 | 69 | 51 | 3 | DOID:7148 (is_marker_for) | |
| Disease | Diabetic Neuralgia | 2.63e-04 | 14 | 51 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 2.63e-04 | 14 | 51 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 2.63e-04 | 14 | 51 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 2.63e-04 | 14 | 51 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 2.63e-04 | 14 | 51 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 2.63e-04 | 14 | 51 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 2.63e-04 | 14 | 51 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 2.63e-04 | 14 | 51 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 2.63e-04 | 14 | 51 | 2 | C0393835 | |
| Disease | Mammary Carcinoma, Human | 2.82e-04 | 525 | 51 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.82e-04 | 525 | 51 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 2.87e-04 | 527 | 51 | 6 | C1458155 | |
| Disease | Breast Carcinoma | 3.21e-04 | 538 | 51 | 6 | C0678222 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 3.46e-04 | 16 | 51 | 2 | DOID:13207 (is_marker_for) | |
| Disease | myopia (is_implicated_in) | 3.46e-04 | 16 | 51 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | otitis media (biomarker_via_orthology) | 3.92e-04 | 17 | 51 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Gastric ulcer | 4.40e-04 | 18 | 51 | 2 | C0038358 | |
| Disease | cD177 antigen measurement | 4.40e-04 | 18 | 51 | 2 | EFO_0021866 | |
| Disease | Malignant neoplasm of breast | 4.76e-04 | 1074 | 51 | 8 | C0006142 | |
| Disease | carotid artery disease (is_marker_for) | 4.92e-04 | 19 | 51 | 2 | DOID:3407 (is_marker_for) | |
| Disease | coagulation factor measurement | 5.46e-04 | 20 | 51 | 2 | EFO_0004634 | |
| Disease | Myocardial Infarction | 6.02e-04 | 95 | 51 | 3 | C0027051 | |
| Disease | Deep Vein Thrombosis | 6.02e-04 | 21 | 51 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 6.02e-04 | 21 | 51 | 2 | C0042487 | |
| Disease | vitiligo (is_implicated_in) | 6.02e-04 | 21 | 51 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 6.02e-04 | 21 | 51 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Hepatitis, Chronic | 6.62e-04 | 22 | 51 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 6.62e-04 | 22 | 51 | 2 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 6.62e-04 | 22 | 51 | 2 | C0149519 | |
| Disease | Cryptogenic Chronic Hepatitis | 6.62e-04 | 22 | 51 | 2 | C0524611 | |
| Disease | myocardial infarction (is_implicated_in) | 6.79e-04 | 99 | 51 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | obesity (is_marker_for) | 7.19e-04 | 101 | 51 | 3 | DOID:9970 (is_marker_for) | |
| Disease | vitronectin measurement | 7.24e-04 | 23 | 51 | 2 | EFO_0021843 | |
| Disease | Cerebral Astrocytoma | 8.57e-04 | 25 | 51 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 8.57e-04 | 25 | 51 | 2 | C0750936 | |
| Disease | Astrocytoma | 8.57e-04 | 25 | 51 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 8.57e-04 | 25 | 51 | 2 | C1704230 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NCPYRARVANYQRDG | 376 | P04040 | |
| QLPAYQGEGPYCNRT | 61 | P30988 | |
| LTEPYRGGCQAQDYT | 826 | Q8IUX7 | |
| RCNSGGVHEEYQLPY | 416 | P36896 | |
| YRQPDGAAYPQCGLN | 191 | P18825 | |
| EGRPCEYNSRIYQNG | 96 | O00622 | |
| TYQCRNGFYPATRGN | 291 | P08603 | |
| RDPNRDAGYIYCQRI | 441 | Q96QD5 | |
| DHIPESDRNYYGCGQ | 236 | O43286 | |
| YRNDYTQGCEPGHRQ | 76 | P49759 | |
| EQRCGNGDPSRYVSN | 456 | Q6UXK2 | |
| CEVQRDPYSNYGHGV | 276 | Q8IUH3 | |
| RCEQCQPGYYGDAQR | 1186 | P98160 | |
| GDNYLCDYQGPRAVG | 191 | Q9BSH5 | |
| CYRSQDYGGRSVAPQ | 301 | Q9NPC2 | |
| YMQNEYRSRGGCPAD | 446 | P35228 | |
| PDRQGLQNDYTEGCY | 761 | O75140 | |
| CQRAEGQCNPLYDQY | 1521 | P46531 | |
| LTRECADQYGQGYPE | 286 | Q86VF7 | |
| PGNNEYDQVRYICET | 216 | Q8NE63 | |
| NDVCRPGRYYEQPDN | 126 | P14415 | |
| ARDVGYPNREGAYQN | 111 | Q5JU85 | |
| VNCPRGFLYFNRQGE | 981 | Q10570 | |
| YRGYCSNVDPRVANV | 451 | P11678 | |
| VNSFCGRYPNGPDYQ | 6 | P20719 | |
| LEYRSSENPVRYGQC | 301 | P00488 | |
| QYAGQGRYEVAVPLC | 216 | Q6P597 | |
| SYRGKDLQENYCRNP | 166 | P14210 | |
| DLQENYCRNPRGEEG | 171 | P14210 | |
| QRTGAGACQEDYRQY | 231 | Q96F15 | |
| NNYYCTRDGRRESVP | 51 | O95182 | |
| GYDGVRNYSRNLNCE | 2586 | O60494 | |
| YYQGTEAEIQRCVRP | 201 | Q8N0W3 | |
| YGHQYTRRANAEPCG | 1346 | Q9Y2I7 | |
| RGYNRATGCIFYNNP | 191 | Q96NT3 | |
| ENYPNAGLTRNYCRN | 1091 | P08519 | |
| EYYPNGGLTRNYCRN | 1311 | P08519 | |
| YPNAGLTENYCRNPD | 1541 | P08519 | |
| PVVRQCYHGNGQSYR | 1611 | P08519 | |
| NPNGDGRCVTCIYYL | 316 | Q9GZT9 | |
| YQYLNGVNPGLIRRC | 266 | O75342 | |
| RPQDCYHGAGEQYRG | 366 | P26927 | |
| TGGYVYRGCESPNLN | 501 | Q6UWX4 | |
| AQENGIYRCYFQEGR | 121 | Q8WVV5 | |
| AGRAPYQENDGYCPD | 756 | Q92613 | |
| GPYQCEIQDRYGGIR | 306 | Q16557 | |
| LREQCYGERGGQYRI | 161 | P59025 | |
| GRNGYDYGQCRLRVE | 71 | Q13242 | |
| GISRNPYCGYDQQTL | 56 | Q969Y0 | |
| RNETGPYQCEIRDRY | 301 | Q00889 | |
| GPYQCEIRDQYGGIR | 306 | Q9UQ74 | |
| GYDNDRPGNLVYRFC | 281 | O95084 | |
| PAERLGRYHQCYNGS | 306 | Q01974 | |
| PLCYHNGVQYRNNEE | 316 | P07996 | |
| YNRNPNACSYGVAVG | 61 | O43759 | |
| EQGNRLREQYGLGPY | 1591 | Q12888 | |
| SCQKTYGRPEGQYLR | 166 | Q9Y6N6 |